Bioactive Chemical Composition of Cannabis Extracts and Cannabinoid Receptors

The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence

(2020) Shafik Boyaji et al.   Current Pain and Headache Reports

The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No “Strain,” No Gain

(2019) Ethan B. Russo   Frontiers in Plant Science

Cannabidiol Adverse Effects and Toxicity

(2019) Marilyn A. Huestis et al.   Current Neuropharmacology

Motor Adaptation Impairment in Chronic Cannabis Users Assessed by a Visuomotor Rotation Task

(2019) Ivan Herreros et al.   Journal of Clinical Medicine

Cannabichromene is a cannabinoid CB2 receptor agonist

(2019) Michael Udoh et al.   BRITISH JOURNAL OF PHARMACOLOGY

Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study

(2019) Alex Capano et al.   POSTGRADUATE MEDICINE

Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay

(2018) L. Cuñetti et al.   TRANSPLANTATION PROCEEDINGS

Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes

(2018) Gemma Navarro et al.   Frontiers in Pharmacology

Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS-16)

(2018) Nicholas Lintzeris et al.   MEDICAL JOURNAL OF AUSTRALIA

Chemometric Analysis of Cannabinoids: Chemotaxonomy and Domestication Syndrome

(2018) E. M. Mudge et al.   Scientific Reports

An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use

(2017) Anastasia S. Suraev et al.   EPILEPSY & BEHAVIOR

Crystal Structure of the Human Cannabinoid Receptor CB 1

(2016) Tian Hua et al.   CELL

The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain

(2016) Simon Haroutounian et al.   CLINICAL JOURNAL OF PAIN

Drug development: The treasure chest

(2015) Brian Owens   NATURE

A systematic review of the antipsychotic properties of cannabidiol in humans

(2015) Tabitha A. Iseger et al.   SCHIZOPHRENIA RESEARCH

Evolution of the Content of THC and Other Major Cannabinoids in Drug-Type Cannabis Cuttings and Seedlings During Growth of Plants*

(2012) Benjamin De Backer et al.   JOURNAL OF FORENSIC SCIENCES

Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects

(2011) Ethan B Russo   BRITISH JOURNAL OF PHARMACOLOGY

Comments on the Definition of theQ2Parameter for QSAR Validation

(2009) Viviana Consonni et al.   Journal of Chemical Information and Modeling

1-(2′,4′-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice

(2009) L. Luongo et al.   NEUROBIOLOGY OF DISEASE

External Validation and Prediction Employing the Predictive Squared Correlation Coefficient  Test Set Activity Mean vs Training Set Activity Mean

(2008) Gerrit Schüürmann et al.   Journal of Chemical Information and Modeling

Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — A short review

(2008) I SVIZENSKA et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY